Zolgensma® data including patients with more severe SMA at baseline further demonstrate therapeutic benefit, including prolonged event-free survival, increased motor function and milestone achievement

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence